Gene expression during normal and FSHD myogenesis

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Tsumagari, Koji ^a   Chang, Shao Chi ^a   Lacey, Michelle ^a,b   Baribault, Carl ^a,b   Chittur, Sridar V ^c   Sowden, Janet ^d   Tawil, Rabi ^d   Crawford, Gregory E ^e   Ehrlich, Melanie ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^e DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; ARGONAUTE PROTEIN; DUX4 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; RNA ISOFORM;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRUCTURE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; DUX4 GENE; EXON; EXTRACELLULAR MATRIX; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MICROARRAY ANALYSIS; MITOCHONDRION; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA GENE; SIGNAL TRANSDUCTION; UPREGULATION; ALTERNATIVE RNA SPLICING; CELL CULTURE; CHROMOSOME 4; DNA MICROARRAY; GENETICS; METABOLISM; PATHOLOGY; SKELETAL MUSCLE;

ALTERNATIVE SPLICING; ARGONAUTE PROTEINS; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 4; DOWN-REGULATION; EXONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; HUMANS; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOBLASTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA ISOFORMS; UP-REGULATION;

EID: 80053349950     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-67     Document Type: Article

References (67)

1. Gene expression profiling of human satellite cells during muscular aging using cDNA arrays. Bortoli S, Renault V, Eveno E, Auffray C, Butler-Browne G, Pietu G, Gene 2003 321 145 154 14637002 (Pubitemid 37421405)
2. Large-scale gene expression analysis of human skeletal myoblast differentiation. Sterrenburg E, Turk R, t Hoen PA, van Deutekom JC, Boer JM, van Ommen GJ, den Dunnen JT, Neuromuscul Disord 2004 14 8-9 507 518 10.1016/j.nmd.2004.03.008 15336692 (Pubitemid 39141706)
3. Comparative gene expression profiling between human cultured myotubes and skeletal muscle tissue. Raymond F, Metairon S, Kussmann M, Colomer J, Nascimento A, Mormeneo E, Garcia-Martinez C, Gomez-Foix AM, BMC Genomics 2010 11 125 10.1186/1471-2164-11-125 20175888
4. Embryonic vs. adult myogenesis: challenging the 'regeneration recapitulates development' paradigm. Wang J, Conboy I, J Mol Cell Biol 2010 2 1 1 4 10.1093/jmcb/mjp027 19797316
5. The myogenic transcriptional network. Yokoyama S, Asahara H, Cell Mol Life Sci 2011 68 11 1843 1849 10.1007/s00018-011-0629-2 21318263
6. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Dixit M, Ansseau E, Tassin A, Winokur S, Shi R, Qian H, Sauvage S, Matteotti C, van Acker AM, Leo O, et al. Proc Natl Acad Sci USA 2007 104 46 18157 18162 10.1073/pnas.0708659104 17984056 (Pubitemid 350210837)
7. A unifying genetic model for facioscapulohumeral muscular dystrophy. Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camano P, Dauwerse JG, Snider L, Straasheijm KR, Jan van Ommen G, Padberg GW, et al. Science 2010 329 1650 1653 10.1126/science.1189044 20724583
8. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. Snider L, Geng LN, Lemmers RJ, Kyba M, Ware CB, Nelson AM, Tawil R, Filippova GN, van der Maarel SM, Tapscott SJ, et al. PLoS Genet 2010 6 10 1001181 10.1371/journal.pgen.1001181 21060811
9. Facioscapulohumeral muscular dystrophy. Tawil R, Neurotherapeutics 2008 5 4 601 606 10.1016/j.nurt.2008.07.005 19019312
10. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, Tapscott SJ, van der Maarel SM, Hayashi Y, Flanigan KM, Hum Mol Genet 2003 12 22 2895 2907 10.1093/hmg/ddg327 14519683 (Pubitemid 37442018)
11. Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Celegato B, Capitanio D, Pescatori M, Romualdi C, Pacchioni B, Cagnin S, Vigano A, Colantoni L, Begum S, Ricci E, et al. Proteomics 2006 6 19 5303 5321 10.1002/pmic.200600056 17013991 (Pubitemid 44547168)
12. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Osborne RJ, Welle S, Venance SL, Thornton CA, Tawil R, Neurology 2007 68 8 569 577 10.1212/01.wnl.0000251269.31442.d9 17151338
13. Distinctive patterns of microRNA expression in primary muscular disorders. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, Lidov HG, Kang PB, North KN, Mitrani-Rosenbaum S, et al. Proc Natl Acad Sci USA 2007 104 43 17016 17021 10.1073/pnas.0708115104 17942673 (Pubitemid 350210983)
14. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Winokur ST, Barrett K, Martin JH, Forrester JR, Simon M, Tawil R, Chung SA, Masny PS, Figlewicz DA, Neuromuscul Disord 2003 13 322 333 10.1016/S0960-8966(02)00284-5 12868502 (Pubitemid 36966161)
15. Myoblasts from affected and non affected FSHD muscles exhibit morphological differentiation defects. Barro M, Carnac G, Flavier S, Mercier J, Vassetzky Y, Laoudj-Chenivesse D, J Cell Mol Med 2010 275 289
16. Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns. Cheli S, Francois S, Bodega B, Ferrari F, Tenedini E, Roncaglia E, Ferrari S, Ginelli E, Meneveri R, PloS one 2011 6 6 20966 10.1371/journal.pone.0020966 21695143
17. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Gabellini D, D'Antona G, Moggio M, Prelle A, Zecca C, Adami R, Angeletti B, Ciscato P, Pellegrino MA, Bottinelli R, et al. Nature 2006 439 7079 973 977 16341202 (Pubitemid 43292415)
18. Fine mapping of the FSHD gene region orientates the rearranged fragment detected by the probe p13E-11. Wright TJ, Wijmenga C, Clark LN, Frants RR, Williamson R, Hewitt JE, Hum Mol Genet 1993 2 10 1673 1678 10.1093/hmg/2.10.1673 7903581 (Pubitemid 23358687)
19. DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Bosnakovski D, Lamb S, Simsek T, Xu Z, Belayew A, Perlingeiro R, Kyba M, Exp Neurol 2008 214 1 87 96 10.1016/j.expneurol.2008.07.022 18723017
20. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. Laoudj-Chenivesse D, Carnac G, Bisbal C, Hugon G, Bouillot S, Desnuelle C, Vassetzky Y, Fernandez A, J Mol Med 2005 83 3 216 224 10.1007/s00109-004-0583-7 15551024 (Pubitemid 40487410)
21. Testing the effects of FSHD candidate gene expression in vertebrate muscle development. Wuebbles RD, Long SW, Hanel ML, Jones PL, Int J Clin Exp Pathol 2010 3 4 386 400 20490329
22. Identification of a novel beta-tubulin subfamily with one member (TUBB4Q) located near the telomere of chromosome region 4q35. van Geel M, van Deutekom JC, van Staalduinen A, Lemmers RJ, Dickson MC, Hofker MH, Padberg GW, Hewitt JE, de Jong PJ, Frants RR, Cytogenet Cell Genet 2000 88 3-4 316 321 10.1159/000015518 10828619 (Pubitemid 30311615)
23. Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level. Klooster R, Straasheijm K, Shah B, Sowden J, Frants R, Thornton C, Tawil R, van der Maarel S, Eur J Hum Genet 2009 17 12 1615 1624 10.1038/ejhg.2009.62 19809486
24. DNaseI hypersensitivity at gene-poor, FSH dystrophy-linked 4q35.2. Xu X, Tsumagari K, Sowden J, Tawil R, Boyle AP, Song L, Furey TS, Crawford GE, Ehrlich M, Nucleic Acids Res 2009 37 22 7381 7393 10.1093/nar/gkp833 19820107
25. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hewitt JE, Lyle R, Clark LN, Valleley EM, Wright TJ, Wijmenga C, van Deutekom JC, Francis F, Sharpe PT, Hofker M, et al. Hum Mol Genet 1994 3 8 1287 1295 10.1093/hmg/3.8.1287 7987304 (Pubitemid 24255461)
26. The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Winokur ST, Bengtsson U, Feddersen J, Mathews KD, Weiffenbach B, Bailey H, Markovich RP, Murray JC, Wasmuth JJ, Altherr MR, et al. Chromosome Res 1994 2 3 225 234 10.1007/BF01553323 8069466 (Pubitemid 24161785)
27. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. Bosnakovski D, Xu Z, Gang EJ, Galindo CL, Liu M, Simsek T, Garner HR, Agha-Mohammadi S, Tassin A, Coppee F, et al. EMBO J 2008 27 20 2766 2779 10.1038/emboj.2008.201 18833193
28. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Kowaljow V, Marcowycz A, Ansseau E, Conde CB, Sauvage S, Matteotti C, Arias C, Corona ED, Nunez NG, Leo O, et al. Neuromuscul Disord 2007 17 611 623 10.1016/j.nmd.2007.04.002 17588759 (Pubitemid 47030917)
29. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Wallace LM, Garwick SE, Mei W, Belayew A, Coppee F, Ladner KJ, Guttridge D, Yang J, Harper SQ, Ann Neurol 2010
30. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). Zeng W, de Greef JC, Chen YY, Chien R, Kong X, Gregson HC, Winokur ST, Pyle A, Robertson KD, Schmiesing JA, et al. PLoS Genet 2009 5 7 1000559 10.1371/journal.pgen.1000559 19593370
31. Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. de Greef JC, Lemmers RJ, van Engelen BG, Sacconi S, Venance SL, Frants RR, Tawil R, van der Maarel SM, Hum Mutat 2009 30 1 11 10.1002/humu.20801 18566966
32. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gabriels J, Beckers MC, Ding H, De Vriese A, Plaisance S, van der Maarel SM, Padberg GW, Frants RR, Hewitt JE, Collen D, et al. Gene 1999 236 1 25 32 10.1016/S0378-1119(99)00267-X 10433963 (Pubitemid 29347656)
33. Hypermethylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cells but not in ICF syndrome cells. Tsien F, Sun B, Hopkins NE, Vedanarayanan V, Figlewicz D, Winokur S, Ehrlich M, Molec Gen Metab 2001 74 322 331 10.1006/mgme.2001.3219 (Pubitemid 33111912)
34. Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? Sandri M, El Meslemani AH, Sandri C, Schjerling P, Vissing K, Andersen JL, Rossini K, Carraro U, Angelini C, J Neuropathol Exp Neurol 2001 60 3 302 312 11245214 (Pubitemid 32209649)
35. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F, Genome Biol 2002 3 7
36. Limma: linear models for microarray data. Smyth GK, Bioinformatics and Computational Biology Solutions using R and Bioconductor New York: Springer, Gentleman R, Carey VS, Dudoit S, Irizarry R, Huber W, 2005 397 420
37. Dexamethasone effects on myoblast proliferation and differentiation. Guerriero V, Florini JR, Endocrinology 1980 106 4 1198 1202 10.1210/endo-106-4- 1198 7188899 (Pubitemid 10135776)
38. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients. Vilquin JT, Marolleau JP, Sacconi S, Garcin I, Lacassagne MN, Robert I, Ternaux B, Bouazza B, Larghero J, Desnuelle C, Gene Ther 2005 12 22 1651 1662 10.1038/sj.gt.3302565 15973444 (Pubitemid 41670355)
39. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der Maarel S, Ehrlich M, Hum Mol Genet 2003 12 2909 2921 10.1093/hmg/ddg323 14506132 (Pubitemid 37442019)
40. The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. Lyle R, Wright TJ, Clark LN, Hewitt JE, Genomics 1995 28 3 389 397 10.1006/geno.1995.1166 7490072
41. Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. Blais A, van Oevelen CJ, Margueron R, Acosta-Alvear D, Dynlacht BD, J Cell Biol 2007 179 7 1399 1412 10.1083/jcb.200705051 18166651
42. Klhl31 is associated with skeletal myogenesis and its expression is regulated by myogenic signals and Myf-5. Abou-Elhamd A, Cooper O, Munsterberg A, Mech Dev 2009 126 10 852 862 10.1016/j.mod.2009.07.006 19643178
43. JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy. Raffaello A, Milan G, Masiero E, Carnio S, Lee D, Lanfranchi G, Goldberg AL, Sandri M, J Cell Biol 2010 191 1 101 113 10.1083/jcb.201001136 20921137
44. OASIS/CREB3L1 induces expression of genes involved in extracellular matrix production but not classical endoplasmic reticulum stress response genes in pancreatic beta-cells. Vellanki RN, Zhang L, Guney MA, Rocheleau JV, Gannon M, Volchuk A, Endocrinology 2010 151 9 4146 4157 10.1210/en.2010-0137 20668028
45. Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients. Davidovic L, Sacconi S, Bechara EG, Delplace S, Allegra M, Desnuelle C, Bardoni B, J Med Genet 2008 45 10 679 685 10.1136/jmg.2008.060541 18628314
46. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Snider L, Asawachaicharn A, Tyler AE, Geng LN, Petek LM, Maves L, Miller DG, Lemmers RJ, Winokur ST, Tawil R, et al. Hum Mol Genet 2009 18 13 2414 2430 10.1093/hmg/ddp180 19359275
47. Apoptosis: quantitative analysis techniques. Mishell BB, Shiiqi SM, Henry C, Chen EL, North J, Gallily R, Slomich M, Miller K, Marbrook J, Parks D, et al. Selected Methods in Cellular Immunology San Francisco WH Freeman 1980 21 22
48. Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili. Abul-Milh M, Wu Y, Lau B, Lingwood CA, Barnett Foster D, Infect Immun 2001 69 12 7356 7364 10.1128/IAI.69.12.7356-7364.2001 11705908 (Pubitemid 33086559)
49. MyoD and the transcriptional control of myogenesis. Berkes CA, Tapscott SJ, Semin Cell Dev Biol 2005 16 4-5 585 595 10.1016/j.semcdb.2005.07.006 16099183 (Pubitemid 41247882)
50. Mechanisms underlying the transcriptional regulation of skeletal myogenesis. Sartorelli V, Caretti G, Curr Opin Genet Dev 2005 15 5 528 535 10.1016/j.gde.2005.04.015 16055324 (Pubitemid 41262409)
51. Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. Wilson EM, Rotwein P, J Biol Chem 2006 281 40 29962 29971 10.1074/jbc.M605445200 16901893 (Pubitemid 44537004)
52. MyoD1 promoter autoregulation is mediated by two proximal E-boxes. Zingg JM, Pedraza-Alva G, Jost JP, Nucleic Acids Res 1994 22 12 2234 2241 10.1093/nar/22.12.2234 8036150 (Pubitemid 24209530)
53. Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from Wnt? Fitzsimons RB, Neuromuscul Disord 2011 21 4 263 271 10.1016/j.nmd.2011.02.002 21377364
54. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy. Macaione V, Aguennouz M, Rodolico C, Mazzeo A, Patti A, Cannistraci E, Colantone L, Di Giorgio RM, De Luca G, Vita G, Acta Neurol Scand 2007 115 2 115 121 10.1111/j.1600-0404.2006.00724.x 17212615 (Pubitemid 46018547)
55. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. Chen YW, Zhao P, Borup R, Hoffman EP, J Cell Biol 2000 151 6 1321 1336 10.1083/jcb.151.6.1321 11121445
56. Gene expression profiling in limb-girdle muscular dystrophy 2A. Saenz A, Azpitarte M, Armananzas R, Leturcq F, Alzualde A, Inza I, Garcia-Bragado F, De la Herran G, Corcuera J, Cabello A, et al. PloS one 2008 3 11 3750 10.1371/journal.pone.0003750 19015733
57. Gene expression profiling highlights defective myogenesis in DMD patients and a possible role for bone morphogenetic protein 4. Sterrenburg E, van der Wees CG, White SJ, Turk R, de Menezes RX, van Ommen GJ, den Dunnen JT, t Hoen PA, Neurobiol Dis 2006 23 1 228 236 10.1016/j.nbd.2006.03.004 16679024 (Pubitemid 43903641)
58. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, Donohue JP, Hall MP, Shiue L, Swanson MS, Thornton CA, et al. Nat Struct Mol Biol 2011 17 2 187 193
59. Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy. Reed P, Porter NC, Strong J, Pumplin DW, Corse AM, Luther PW, Flanigan KM, Bloch RJ, Ann Neurol 2006 59 2 289 297 10.1002/ana.20750 16437580 (Pubitemid 43202482)
60. Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells. Giorgino F, Pedrini MT, Matera L, Smith RJ, J Biol Chem 1997 272 11 7455 7463 10.1074/jbc.272.11.7455 9054447 (Pubitemid 27166458)
61. Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids. Shah OJ, Kimball SR, Jefferson LS, Biochem J 2000 347 Pt 2 389 397 10749668 (Pubitemid 30229386)
62. Glucocorticoids and muscle catabolism. Hasselgren PO, Curr Opin Clin Nutr Metab Care 1999 2 3 201 205 10.1097/00075197-199905000-00002 10456248 (Pubitemid 129627818)
63. Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles. Combaret L, Taillandier D, Dardevet D, Bechet D, Ralliere C, Claustre A, Grizard J, Attaix D, Biochem J 2004 378 Pt 1 239 246 14636157 (Pubitemid 38299563)
64. Transforming growth factor-beta enhances matrix metalloproteinase-2 expression and activity through AKT in fibroblasts derived from angiofibromas in patients with tuberous sclerosis complex. Lee CH, Hong CH, Yu HS, Chen GS, Yang KC, Br J Dermatol 2010 163 6 1238 1244 10.1111/j.1365-2133.2010.09971.x 20698845
65. The Rho family of small GTPases: crucial regulators of skeletal myogenesis. Bryan BA, Li D, Wu X, Liu M, Cell Mol Life Sci 2005 62 14 1547 1555 10.1007/s00018-005-5029-z 15905962 (Pubitemid 41021578)
66. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Goetsch SC, Hawke TJ, Gallardo TD, Richardson JA, Garry DJ, Physiol Genomics 2003 14 3 261 271 12799472 (Pubitemid 37345234)
67. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P, Nature 2007 450 7170 736 740 10.1038/nature06322 18046414 (Pubitemid 350207689)